EP4165158A1 - A disinfectant and cleaning composition - Google Patents
A disinfectant and cleaning compositionInfo
- Publication number
- EP4165158A1 EP4165158A1 EP21730617.4A EP21730617A EP4165158A1 EP 4165158 A1 EP4165158 A1 EP 4165158A1 EP 21730617 A EP21730617 A EP 21730617A EP 4165158 A1 EP4165158 A1 EP 4165158A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight
- composition
- acid
- hydrogen peroxide
- oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 415
- 238000004140 cleaning Methods 0.000 title claims abstract description 38
- 239000000645 desinfectant Substances 0.000 title claims abstract description 32
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 256
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 190
- 239000004310 lactic acid Substances 0.000 claims abstract description 94
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 94
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims abstract description 89
- 238000000034 method Methods 0.000 claims abstract description 30
- 230000000249 desinfective effect Effects 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 108
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 90
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 claims description 66
- -1 builders Substances 0.000 claims description 49
- 239000002904 solvent Substances 0.000 claims description 47
- 239000002736 nonionic surfactant Substances 0.000 claims description 37
- 150000003839 salts Chemical class 0.000 claims description 36
- 239000002280 amphoteric surfactant Substances 0.000 claims description 32
- 239000004094 surface-active agent Substances 0.000 claims description 31
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 30
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 26
- 235000013922 glutamic acid Nutrition 0.000 claims description 26
- 239000004220 glutamic acid Substances 0.000 claims description 26
- CMDUJTDTOWOKBQ-UHFFFAOYSA-N N-methyl-N-undecylhydroxylamine Chemical compound CCCCCCCCCCCN(C)O CMDUJTDTOWOKBQ-UHFFFAOYSA-N 0.000 claims description 25
- 239000002253 acid Substances 0.000 claims description 25
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 25
- 229930182470 glycoside Natural products 0.000 claims description 24
- 150000002338 glycosides Chemical class 0.000 claims description 24
- 235000015099 wheat brans Nutrition 0.000 claims description 24
- 239000000654 additive Substances 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 239000003205 fragrance Substances 0.000 claims description 8
- 150000001298 alcohols Chemical class 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 239000003002 pH adjusting agent Substances 0.000 claims description 6
- 239000006179 pH buffering agent Substances 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- 239000002738 chelating agent Substances 0.000 claims description 5
- 150000002170 ethers Chemical class 0.000 claims description 5
- 239000003352 sequestering agent Substances 0.000 claims description 5
- 230000003064 anti-oxidating effect Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 239000003605 opacifier Substances 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 230000008719 thickening Effects 0.000 claims description 3
- REICWNSBQADONN-UHFFFAOYSA-N 2-hydroxy-n,n-dimethyldodecan-1-amine oxide Chemical compound CCCCCCCCCCC(O)C[N+](C)(C)[O-] REICWNSBQADONN-UHFFFAOYSA-N 0.000 claims description 2
- UXJZLKNQKNMGDH-UHFFFAOYSA-N 3-dodecoxy-1-hydroxy-n,n-bis(2-hydroxyethyl)propan-1-amine oxide Chemical compound CCCCCCCCCCCCOCCC(O)[N+]([O-])(CCO)CCO UXJZLKNQKNMGDH-UHFFFAOYSA-N 0.000 claims description 2
- QGSXGOYRCUERLJ-UHFFFAOYSA-N 3-dodecoxy-2-hydroxy-n,n-bis(2-hydroxyethyl)propan-1-amine oxide Chemical compound CCCCCCCCCCCCOCC(O)C[N+]([O-])(CCO)CCO QGSXGOYRCUERLJ-UHFFFAOYSA-N 0.000 claims description 2
- 108010077895 Sarcosine Proteins 0.000 claims description 2
- 239000012459 cleaning agent Substances 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- ONHFWHCMZAJCFB-UHFFFAOYSA-N myristamine oxide Chemical compound CCCCCCCCCCCCCC[N+](C)(C)[O-] ONHFWHCMZAJCFB-UHFFFAOYSA-N 0.000 claims description 2
- DZJFABDVWIPEIM-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)dodecan-1-amine oxide Chemical compound CCCCCCCCCCCC[N+]([O-])(CCO)CCO DZJFABDVWIPEIM-UHFFFAOYSA-N 0.000 claims description 2
- DBPADWNGEAMSFC-UHFFFAOYSA-N n,n-dibutyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+]([O-])(CCCC)CCCC DBPADWNGEAMSFC-UHFFFAOYSA-N 0.000 claims description 2
- OCKVXAVACGVODF-UHFFFAOYSA-N n,n-dibutyltetradecan-1-amine oxide Chemical compound CCCCCCCCCCCCCC[N+]([O-])(CCCC)CCCC OCKVXAVACGVODF-UHFFFAOYSA-N 0.000 claims description 2
- GORQZFWSXIRBGQ-UHFFFAOYSA-N n,n-dimethylheptadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCC[N+](C)(C)[O-] GORQZFWSXIRBGQ-UHFFFAOYSA-N 0.000 claims description 2
- IBOBFGGLRNWLIL-UHFFFAOYSA-N n,n-dimethylhexadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)[O-] IBOBFGGLRNWLIL-UHFFFAOYSA-N 0.000 claims description 2
- DLPZOAYAGDEIHC-UHFFFAOYSA-N n,n-dimethylpentadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCC[N+](C)(C)[O-] DLPZOAYAGDEIHC-UHFFFAOYSA-N 0.000 claims description 2
- VHXSGTCOHZCUKB-UHFFFAOYSA-N n,n-dimethyltridecan-1-amine oxide Chemical compound CCCCCCCCCCCCC[N+](C)(C)[O-] VHXSGTCOHZCUKB-UHFFFAOYSA-N 0.000 claims description 2
- KOCNEHDOMLOUNT-UHFFFAOYSA-N n,n-dipropyldodecan-1-amine oxide Chemical compound CCCCCCCCCCCC[N+]([O-])(CCC)CCC KOCNEHDOMLOUNT-UHFFFAOYSA-N 0.000 claims description 2
- ZLMKHKTZEMXAAJ-UHFFFAOYSA-N n,n-dipropylhexadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCC[N+]([O-])(CCC)CCC ZLMKHKTZEMXAAJ-UHFFFAOYSA-N 0.000 claims description 2
- FLZHCODKZSZHHW-UHFFFAOYSA-N n,n-dipropyltetradecan-1-amine oxide Chemical compound CCCCCCCCCCCCCC[N+]([O-])(CCC)CCC FLZHCODKZSZHHW-UHFFFAOYSA-N 0.000 claims description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 56
- 238000012360 testing method Methods 0.000 description 41
- 230000000694 effects Effects 0.000 description 38
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 28
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 25
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical class OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 24
- 239000004571 lime Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 18
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 17
- 235000011941 Tilia x europaea Nutrition 0.000 description 17
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 16
- 238000011156 evaluation Methods 0.000 description 16
- 239000000344 soap Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 15
- 229960003237 betaine Drugs 0.000 description 13
- 239000004519 grease Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000006260 foam Substances 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 241001331781 Aspergillus brasiliensis Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 239000004579 marble Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000000855 fungicidal effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 239000002023 wood Substances 0.000 description 5
- 241000194029 Enterococcus hirae Species 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241000711467 Human coronavirus 229E Species 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000005238 degreasing Methods 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 230000003253 viricidal effect Effects 0.000 description 4
- AURFNYPOUVLIAV-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]-2-hydroxyacetic acid Chemical compound OC(=O)C(O)N(CC(O)=O)CCN(CC(O)=O)CC(O)=O AURFNYPOUVLIAV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical class OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 229920000388 Polyphosphate Polymers 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000013043 chemical agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000001205 polyphosphate Substances 0.000 description 3
- 235000011176 polyphosphates Nutrition 0.000 description 3
- 238000001303 quality assessment method Methods 0.000 description 3
- 238000011158 quantitative evaluation Methods 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- UTCHNZLBVKHYKC-UHFFFAOYSA-N 2-hydroxy-2-phosphonoacetic acid Chemical compound OC(=O)C(O)P(O)(O)=O UTCHNZLBVKHYKC-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 2
- 241000700618 Vaccinia virus Species 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- YWMWZKYVGNWJPU-UHFFFAOYSA-N [bis[6-[bis(phosphonomethyl)amino]hexyl]amino]methylphosphonic acid Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCCCCCN(CP(O)(=O)O)CCCCCCN(CP(O)(O)=O)CP(O)(O)=O YWMWZKYVGNWJPU-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000016571 aggressive behavior Effects 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000008570 general process Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 150000003009 phosphonic acids Chemical class 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 208000016261 weight loss Diseases 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 1
- AMRBZKOCOOPYNY-QXMHVHEDSA-N 2-[dimethyl-[(z)-octadec-9-enyl]azaniumyl]acetate Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CC([O-])=O AMRBZKOCOOPYNY-QXMHVHEDSA-N 0.000 description 1
- MUZDXNQOSGWMJJ-UHFFFAOYSA-N 2-methylprop-2-enoic acid;prop-2-enoic acid Chemical compound OC(=O)C=C.CC(=C)C(O)=O MUZDXNQOSGWMJJ-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- MPXCBQCUNKTGGN-UHFFFAOYSA-N CN(C)C.OP(=O)OP(O)=O Chemical compound CN(C)C.OP(=O)OP(O)=O MPXCBQCUNKTGGN-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229940120146 EDTMP Drugs 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000018208 Hyperimmunoglobulinemia D with periodic fever Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010072219 Mevalonic aciduria Diseases 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical class OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- BCXBKOQDEOJNRH-UHFFFAOYSA-N NOP(O)=O Chemical class NOP(O)=O BCXBKOQDEOJNRH-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- RXTCWPTWYYNTOA-UHFFFAOYSA-N O=P1OCCCCCO1 Chemical compound O=P1OCCCCCO1 RXTCWPTWYYNTOA-UHFFFAOYSA-N 0.000 description 1
- RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 1
- XZTIUQAKASWQJM-UHFFFAOYSA-N OP(=O)OP(O)=O.NCC1=CC=CC=C1 Chemical compound OP(=O)OP(O)=O.NCC1=CC=CC=C1 XZTIUQAKASWQJM-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 description 1
- 239000013527 degreasing agent Substances 0.000 description 1
- 238000005237 degreasing agent Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 150000004656 dimethylamines Chemical class 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- TVQLLNFANZSCGY-UHFFFAOYSA-N disodium;dioxido(oxo)tin Chemical compound [Na+].[Na+].[O-][Sn]([O-])=O TVQLLNFANZSCGY-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002193 fatty amides Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940061566 glycereth-17 cocoate Drugs 0.000 description 1
- 229940055015 glycereth-20 Drugs 0.000 description 1
- 229940088638 glycereth-7 Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 231100000058 in vitro skin irritation / corrosion testing Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000002050 international nonproprietary name Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000009972 noncorrosive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- CTYRPMDGLDAWRQ-UHFFFAOYSA-N phenyl hydrogen sulfate Chemical compound OS(=O)(=O)OC1=CC=CC=C1 CTYRPMDGLDAWRQ-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003214 poly(methacrylonitrile) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 229920005606 polypropylene copolymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- KVZLHPXEUGJPAH-QNDGGIRCSA-N rac-lactic acid Chemical compound C[C@@H](O)C(O)=O.C[C@H](O)C(O)=O KVZLHPXEUGJPAH-QNDGGIRCSA-N 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940079864 sodium stannate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000005402 stannate group Chemical group 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DTXLBRAVKYTGFE-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethylamino)-3-hydroxybutanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)C(O)C(C([O-])=O)NC(C([O-])=O)CC([O-])=O DTXLBRAVKYTGFE-UHFFFAOYSA-J 0.000 description 1
- GYBINGQBXROMRS-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethylamino)butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O GYBINGQBXROMRS-UHFFFAOYSA-J 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 description 1
- OHOTVSOGTVKXEL-UHFFFAOYSA-K trisodium;2-[bis(carboxylatomethyl)amino]propanoate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C(C)N(CC([O-])=O)CC([O-])=O OHOTVSOGTVKXEL-UHFFFAOYSA-K 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
- C11D3/2086—Hydroxy carboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/36—Organic compounds containing phosphorus
- C11D3/361—Phosphonates, phosphinates or phosphonites
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3942—Inorganic per-compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3947—Liquid compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/265—Carboxylic acids or salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/36—Organic compounds containing phosphorus
Definitions
- a disinfectant and cleaning composition A disinfectant and cleaning composition
- the present invention relates to the field of disinfection.
- it relates to a stable non-toxic and non- corrosive hydrogen peroxide-containing composition efficient for being used as disinfectant and cleaning composition. It also relates to processes for its preparation and a method for its use.
- Hydrogen peroxide solutions have been used for many years for a variety of purposes, including bleaching, disinfecting, and cleaning a variety of surfaces ranging from skin, hair, mucous membranes to contact lenses, instruments, household and industrial surfaces,
- hydrogen peroxide compositions are specially attractive because hydrogen peroxide displays broad spectrum antimicrobial activity and because it decomposes into innocuous products (i.e. water and oxygen). Broad spectrum antimicrobial activity is important in situations where harmful organisms are present, but their identity is not known.
- the disinfectant activity of the hydrogen peroxide it is also a reference product due to its versatile effect as cleaner which helps to remove limescale, calcium stains and yellow spots.
- hydrogen peroxide also involves some drawbacks.
- One of the most important problems of hydrogen peroxide compositions is the inherent instability of hydrogen peroxide solutions and the length of time required for hydrogen peroxide to disinfect a surface to which it had been applied.
- hydrogen peroxide solutions begin to decompose into oxygen gas and water within an extremely short time.
- Typical hydrogen peroxide solutions in use for the above mentioned purposes are in the range from about 0.5% to about 10% by weight of hydrogen peroxide in water.
- these stabilizing agents are chelators or sequestering agents which are added to hydrogen peroxide solutions to combat decomposition due to the presence of trace impurities (mainly dissolved metals).
- trace impurities mainly dissolved metals.
- Many types of compounds have been used to fill this function, such as, diols; quinones; stannate salts; pyrophosphates; phenolsulfate; sodium stannate; N,N-lower alkyl aniline; sulfamic acid; sulfolane; and di-straight chain lower alkyl sulfones and sulfoxides; phosphonic acids and their salts; various aromatic compounds and amino carboxylic acid salts; acrylic acid polymers; polyphosphates; polyamino polyphosphonic acids and/or their salt.
- hydrogen peroxide is a strong oxidizer and can be corrosive to the eyes, skin, and respiratory system, causing burns to the skin and tissue damage. In fact, they are associated with occupational safety. In lower concentrations as “household-grade” concentrations, hydrogen peroxide is generally considered safe to use, but should never be inhaled and/or ingested. In fact, even at low concentrations, the hydrogen peroxide should be handled and stored with care whether at home or in the workplace.
- hydrogen peroxide is highly corrosive having important material imcompatibility problems.
- hydrogen peroxide can damage both metallic surface such as tubes and metal instruments, and organic material surfaces such carbonate based surfaces (such as marble) which is neither desirable.
- the reduction of the undesirable corrosive effect of hydrogen peroxide solutions is achieved by lowering the amount of active ingredients or the increase of the pH values, compromising its disinfectant and/or cleaning activity.
- the cleaning activity is specially critical implying the removal of lime, calcium stains, yellow spots as well as the removal of soap (foam, scum and stains) and grease, the addition of active ingredients having one or more of the above-mentioned activities is required.
- the inventors have provided a stable hydrogen peroxide composition having an efficient disinfectant activity and achieving a very thorough and at the same time broad cleaning effect.
- the inventors have found that the use of a low amount of hydrogen peroxide (from 0.5% to 4%) and lactic acid (from 0.25% to 0.8%) in combination with an amount of organic phosphonic acid from 0.1% to 0.5% allows providing a stable composition for being stored without decomposition of the hydrogen peroxide; and having at the same time the appropriate pH and concentration of active ingredients for providing an efficient dual disinfectant and cleaning effect.
- the organic phosphonic acid is known to efficiently stabilize hydrogen peroxide.
- the organic phosphonic acid has a negative effect for the lactic acid present in the composition, greatly compromising its anti lime effect.
- the increase of the amount of the lactic acid in the presence of the organic phosphonic acid does not improve the anti lime effect of the composition but undesirably increase the incompatibility with the materials commonly use at both homeplace and workplace and instruments.
- the decrease in the amount of the lactic acid below the typically concentration used in this type of compositions until the claimed amount of lactic acid (from 0.25% to 0.8%) of the compositions of the present invention in combination with an amount of organic phophonic acid from 0.1% to 0.5% allows having an optimal stabilization of the hydrogen peroxide and the dual and broad disinfectant and cleaning effect without compromising the safety, toxicity and compatibility with the surfaces to treat.
- the composition of the present invention has a broad spectrum antimicrobial activity at short exposure time (about 5 min agaisnt bacterias and enveloped viruses).
- the composition has proved to be efficient against gram-positive and gram negative bacteria, fungi and enveloped virus without the need of rinsing the surface after application even at low amounts of hydroxy peroxide.
- due to its harmlessness it is also appropriate for the treatment of surfaces which are usually in contact with food.
- the composition of the invention is useful as cleaning product because it is capable of removing lime, soap (foam, scum and stains) and grease from non living surfaces, without damaging the treated surface thanks to the very low or nule reactivity towards materials, substrates and tissues. Therefore, the composition of the invention have a efficient cleaning activity of any surface regardless that a lime scale effect, a soap removal activity and/or a grease removal effect is needed. In fact, the composition of the invention includes the appropriate active cleaning ingredients and achieves a very thorough and broad cleaning effect without affecting the disinfectant activity nor the stability of the composition.
- the present application also includes a toxicity, irritability and corrosion test which shows that the composition of the invention can be considered non-toxic, non-irritant and safety for being use as disinfectant and cleaning of non-living surfaces even those which are formed or have metals or delicate organic materials.
- the use of the composition of the invention with a low amount of the active ingredients, particularly hydrogen peroxide results in an improved shelf life and ease packaging without involving any health and safety hazards.
- the first aspect of the invention relates to a composition
- a composition comprisingTrom 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid; from 0.25% to 0.8% by weight of lactic acid; and having a pH from 2 to 3.6.
- the second aspect of the invention relates to a process for the preparation of the composition of the first aspect of the invention.
- the third aspect of the invention relates to a use of the composition of the first aspect of the invention as disinfectant and cleaner.
- the fourth aspect of the invention relates to a method of disinfecting and cleaning a non-living surface comprising applying a composition as defined in the first aspect of the invention.
- any ranges given include both the lower and the upper endpoints of the range. Ranges and values given, such as temperatures, times, and the like, should be considered approximate, unless specifically stated.
- percentage (%) by weight refers to the percentage of each ingredient of the composition in relation to the total weight.
- the first aspect refers to a stable disinfectant and cleaning comprising from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; and having a pH from 2 to 3.6.
- the composition comprises from 0.5% to 4% by weight of hydrogen peroxide. In an embodiment, the composition comprises from 1% to 3.5% by weight of hydrogen peroxide. In an embodiment, the composition comprises from 1% to 3% by weight of hydrogen peroxide. In an embodiment, the composition comprises from 1.5% to 3% by weight of hydrogen peroxide. In an embodiment, the composition comprises from 1.5% to 2.5% by weight of hydrogen peroxide. In an embodiment, the composition comprises about 1.5% by weight of hydrogen peroxide. In an embodiment, the composition comprises from 0.5% to lower than 2% by weight of hydrogen peroxide. In an embodiment, the composition comprises from 1% to lower than 2% by weight of hydrogen peroxide. In an embodiment, the composition comprises about 1.5% by weight of hydrogen peroxide.
- the composition comprises from equal to or higher than 2% to 4% by weight of hydrogen peroxide. In an embodiment, the composition comprises from equal to or higher than 2.5% to 3.5% by weight of hydrogen peroxide. In an embodiment, the composition comprises about 2.5% by weight of hydrogen peroxide.
- the compositions of the present invention are advantegeous because have a dual effect as disinfectant and cleaner (anti-lime and soap removal). Particularly, the compositions of the present invention have bactericidal, fungicidal and viricidal activity.
- the composition of the present invention comprises from 0.1% to 0.5% by weight of an organic phosphonic acid. In an embodiment, the composition comprises from 0.18% to 0.4% by weight of an organic phosphonic acid. In an embodiment, the composition comprises from 0.2% to 0.35% by weight of an organic phosphonic acid. In an embodiment, the composition comprises from 0.2% to 0.3% by weight of an organic phosphonic acid. In an embodiment, the composition comprises about 0.3% by weight of an organic phosphonic acid.
- organic phosphonic acid encompasses organic monophosphonic acids and organic biphosphonic acids.
- the composition is one wherein the organic phosphonic acid is selected from th group consisting of dimethylaminomethane diphosphonic acid, 1-amino-1-phenylmethane diphosphonic acid, amino tri-(methylene phosphonic acid) (ATMP), ethylene diamine tetra -(methylene phosphonic acid)
- the organic phosphonic acid is selected from th group consisting of dimethylaminomethane diphosphonic acid, 1-amino-1-phenylmethane diphosphonic acid, amino tri-(methylene phosphonic acid) (ATMP), ethylene diamine tetra -(methylene phosphonic acid)
- the composition is one wherein the organic phosphonic acid is 1- hydroxyethylidene-1 , 1-diphosphonic acid.
- the terms 1 -hydroxyethylidene-1 , 1-diphosphonic acid and etidronic acid, and the abbreviature HEDP refers to the same compound which are commercially available with the name Dequest 2010 LC.
- the composition of the invention comprises from 0.25% to 0.8% by weight of lactic acid. In an embodiment, the composition comprises from 0.25% to 0.75% by weight of lactic acid. In an embodiment, the composition comprises from 0.3% to 0.75% by weight of lactic acid. In an embodiment, the composition comprises from 0.35% to 0.75% by weight of lactic acid. In an embodiment, the composition comprises from 0.35% to 0.5% by weight of lactic acid. In an embodiment, the composition comprises about 0.35% by weight of lactic acid.
- lactic acid is the International Non-proprietary Name of 2-hydroxypropionic acid having the CAS number 50-21-5.
- the structure of the lactic acid corresponds to the following formula:
- the composition comprises: from 1% to 3.5% by weight of hydrogen peroxide; from 0.18% to 0.4% by weight of an organic phosphonic acid, particularly 1 -hydroxyethy lidene- 1,1- diphosphonic acid; from 0.25% to 0.75% by weight of lactic acid; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethy lidene- 1,1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition comprises: froml .5% to 3% by weight of hydrogen peroxide; from 0.2% to 0.3% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.35% to 0.75% by weight of lactic acid; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition comprises: from 1.5% to 2.5% by weight of hydrogen peroxide; from 0.2% to 0.3% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.35% to 0.5% by weight of lactic acid; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition comprises: about 1.5% by weight of hydrogen peroxide; about 0.3% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 -diphosphonic acid; about 0.35% by weight of lactic acid; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition comprises: about 2.5% by weight of hydrogen peroxide; about 0.3% by weight of an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1 -diphosphonic acid; about 0.35% by weight of lactic acid; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention further comprises one or more additives.
- the composition further comprises one or more additives selected from the group consisting of solvents, surfactants, builders, pH adjusting agent, pH buffering agents, thickening/viscosity modifying agent, perfumes or fragrances, preservatives; dyes and other colorants; UV absorbents or antioxidizing agents, fabric softening compositions; static control agents; optical opacifiers, and suds regulants.
- the composition of the invention comprises one or more solvents. In an embodiment, the composition of the invention comprises one or more miscible organic solvent. In an embodiment, the composition of the invention comprises one or more miscible organic solvent being water-miscible organic solvents. Examples of water-miscibles solvents includes alcohols, ethers, ketones, esters and a mixture thereof.
- the composition of the invention comprises one or more water-miscible organic solvents selected from the group consisting of (C2-Ce) alcohol, (C1-C4) alkyl-CO-(Ci-C4) alkyl, (C1-C4) alkyl-O- (C 1 -C 4 ) alkyl, (C 1 -C 4 ) alkyl-C0-0-(Ci-C4) alkyl and a mixture thereof.
- the amount of the solvents in the compositions of the present invention is from 2 to 7% by weight; particularly from 3 to 6% by weight.
- the composition of the invention comprises one or more (C2-C6)alcohols.
- the term “alcohol” refers to an “alkane” wherein at least one hydrogen atom is substituted by a hydroxyl group and which contains the number of carbon atoms specified in the description or claims.
- the term “alkane” refers to a saturated, branched or linear hydrocarbon which contains the number of carbon atoms specified in the description or claims. Examples include ethanol, n-propanol, iso-propanol, butanol, iso-butanol, and sec- butanol.
- alkyl refers to a saturated straight, or branched hydrocarbon chain which contains the number of carbon atoms specified in the description or claims.
- the solvent is one or more alcohols as defined above.
- the composition of the invention comprises ethanol as alcoholic solvent.
- the solvent is one or more ethers of formula (C 1 -C 4 ) alkyl-0-(Ci-C4).
- the composition of the invention comprises one or more ethers as a solvents selected from the group consisting of (3-methoxy-3-methyl-1-butanol) (MMB), di(propylene glycol) n-butyl ether (commercially available with the name Dowanol Dpnb), di(propylene)glycol and a mixture thereof.
- MMB (3-methoxy-3-methyl-1-butanol)
- Dpnb di(propylene)glycol
- the composition comprises di (propylene glycol) n-butyl ether as solvent.
- the composition comprises di(propylene)glycol as solvent.
- the composition comprises a combination of one or more alcohols as defined above and one or more ethers as defined above.
- the composition comprises a mixture of ethanol and di (propylene glycol) n-butyl ether as solvents.
- the composition of the invention comprises: from 05% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 2 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether, di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 1% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 -diphosphonic acid; from 0.2% to 0.8% by weight of lactic acid; from 3 to 6 % by weight of ethanol; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 1% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 -diphosphonic acid; from 0.2% to 0.8% by weight of lactic acid; from 3 to 6 % by weight of a mixture of ethanol and di (propylene glycol) n-butyl ether; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 1% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 -diphosphonic acid; from 0.2% to 0.8% by weight of lactic acid; from 3 to 6 % by weight of di(propylene)glycol; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 2 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether, di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1 % to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 6 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether, di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 2 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether, di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 6 % by weight of ethanol; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 6 % by weight of a mixture of ethanol and di (propylene glycol) n-butyl ether; and and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 6 % by weight of di(propylene)glycol; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 2 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether, di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 6 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether, di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- composition i.e. hydrogen peroxide, organic phophoric acid and lactic acid
- pH value also applies to the above mentioned composition comprising one or more solvents.
- composition of the invention further comprises one or more surfactants as additive.
- surfactant refers to a material which lowers the surface tension of a liquid and the interfacial tension between two liquids, allowing their easier spreading.
- Surfactants have a hydrophilic head that is attracted to water molecules and a hydrophobic tail that repels water and simultaneously attaches itself to oil and grease in dirt. These opposing forces loosen the dirt and suspend it in the water, having the ability to remove it from surfaces, when surfactants are dissolved in water.
- the amount of the surfactant in the composition of the present invention is from 0.1-6.5% by weigth of the composition. In an embodiment, the amount of the surfactant in the composition of the present invention is from 0.5% to 5% by weight of the composition.
- the amount of the surfactant in the composition of the present invention is from 1% to 4% by weight of the composition. In an embodiment, the amount of the surfactant in the composition of the present invention is from 1% to 3% by weight of the composition. In an embodiment, the amount of the surfactant in the composition of the present invention is from 1.5% to 2% by weight of the composition.
- the surfactant can be divided into three different groups: non-ionic, ionic (either anionic or cationic) or zwitterionic (or amphoteric wherein the head of the surfactant contains two oppositely charged groups) surfactants.
- the composition of the invention further comprises one or more amphoteric surfactant.
- amphoteric surfactant encompasses a surfactant that contains a head with two oppositely charged groups (e.g., positive and negative), Thus, amphoteric surfactants may be anionic (negatively charged), cationic (positively charged) or non-ionic (no charge) in solution, depending on the acidity or pH of the water.
- the composition further comprises one or more amphoteric surfactants selected from the group consisting of amine oxides and betaines
- amine oxides appropriate for the present invention include, but without limited to, decyldimethyl-aminoxide, dodecyldimethylamine oxide, tridecyldimethylamine oxide, tetradecyldimethylamine oxide, pentadecyldimethylamine oxide, hexadecyldimethylamine oxide, heptadecyldimethylamine oxide, octadecyldimethylaine oxide, dodecyldipropylamine oxide, tetradecyldipropylamine oxide, hexadecyldipropylamine oxide, tetradecyldibutylamine oxide, octadecyldibutylamine oxide, bis(2-hydroxyethyl)dodecylamine oxide, bis(2- hydroxyethyl
- betaines appropriate for the present invention include, but without limited to, amidobetaines, amidosulfobetaines, coco dimethyl carboxymethyl betaine, cocoamidopropyl betaine, cocobetaine, lauryl amidopropyl betaine, oleyl betaine, lauryl dimethyl carboxymethyl betaine, lauryl dimethyl alphacarboxyethyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxyethyl)carboxymethyl betaine, stearyl bis- (2-hydroxypropyl)carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis-(2- hydroxypropyl)alpha-carboxyethyl betaine, coco dimethyl sulfopropyl betaine, stearyl dimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, or lauryl bis-(2-hydroxybe
- the composition further comprises one or more amphoteric surfactants selected from the group consisting of amine oxides as defined above.
- the composition further comprises decyldimethyl- aminoxide.
- the decyldimethyl-aminoxide is commercially available by the name tegotens® DO.
- the amount of amphoteric surfactants is from 0, 1 to 2.5% by weight of the composition. In an embodiment, if present, the amount of amphoteric surfactants is from 0.2 to 1.5% by weight of the composition. In an embodiment, if present, the amount of amphoteric surfactants is from 0,3 to 1% by weight of the composition. In an embodiment, if present, the amount of amphoteric surfactants is from 0,4 to 1% by weight of the composition, In an embodiment, if present, the amount of amphoteric surfactants is from 0.4 to 0.6% by weight of the composition.
- the composition of the invention further comprises one or more non-ionic surfactant
- non-ionic surfactants appropriate for the present invention include, but without limited to, ethoxylated and propoxylated alcohols, especially C 10-20 alcohols reacted with 2 to 100 moles of ethylene oxide and/or propylene oxide per mole of alcohol, especially ethoxylates of primary alcohols containing about 8 to 18 carbon atoms in a straight or branched chain configuration which have been reacted with about 5 to 30 moles of ethylene oxide, for example, the ethoxylates of decyl alcohol, cetyl alcohol, lauryl alcohol, or myristyl alcohol; ethoxylates of secondary aliphatic alcohols containing 8 to 18 carbon atoms in a straight or branched chain configuration with 5 to 30 moles of ethylene oxide; condensation of aliphatic alcohols containing about 8 to about 20 carbon atoms with ethylene oxide and propylene oxide; polyethylene glycol and polyethylene oxide;
- the composition of the invention further comprises one or more non-ionic surfactant as defined in the present invention.
- the composition of the invention further comprises a non-ionic surfactant selected from the group consisting of C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide and a mixture thereof. If present, the amount of non-ionic surfactants in the composition of the present invention is from 0 % to 4% by weight. In an embodiment, the amount of non-ionic surfactants in the composition of the present invention is from 0.2% to 4% by weight. In an embodiment, the amount of non-ionic surfactants in the composition of the present invention is from 0.5 % to 2% by weight.
- the amount of non-ionic surfactants in the composition of the present invention is from 1 % to 2% by weight. In an embodiment, the amount of non-ionic surfactants in the composition of the present invention is from 1.2 % to 1.7% by weight. In an embodiment, the amount of nonionic surfactants in the composition of the present invention is about 1.5% by weight.
- the composition of the invention further comprises a non-ionic surfactant being C8/C10 wheat bran glycoside in an amount from 0.2 to 4% by weight of the composition. In an embodiment, the composition of the invention further comprises a non-ionic surfactant being C8/C10 wheat bran glycoside in an amount from 0.5 to 2% by weight of the composition. In an embodiment, the composition of the invention further comprises a non-ionic surfactant being C8/C10 wheat bran glycoside in an amount from 0.8 to 1.5% by weight of the composition. In an embodiment, the composition of the invention further comprises a non-ionic surfactant being C8/C10 wheat bran glycoside in an amount about 1% by weight of the composition.
- the composition of the invention further comprises a non-ionic surfactant being, capryloyl/capryl methyl glucamide in an amount from 0.2 to 4 % by weight of the composition. In an embodiment, the composition of the invention further comprises a non-ionic surfactant being, capryloyl/capryl methyl glucamide in an amount from 0.3 to 2 % by weight of the composition. In an embodiment, the composition of the invention further comprises a non-ionic surfactant being, capryloyl/capryl methyl glucamide in an amount from 0.4 to 1.5 % by weight of the composition.
- the composition of the invention further comprises a non-ionic surfactant being, capryloyl/capryl methyl glucamide in an amount from 0.5 to 0.8 % by weight of the composition. In an embodiment, the composition of the invention further comprises a non-ionic surfactant being, capryloyl/capryl methyl glucamide in an amount fabout 0.5 % by weight of the composition.
- the composition of the invention further comprises one or more amphoteric surfactants and one or more non-ionic surfactant as defined in the present invention.
- the composition of the invention further comprises decyldimethyl-aminoxide (commercially available by the name tegotens® DO) as amphoteric surfactant and a C8/C 10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof as non-ionic surfactants.
- the composition of the invention comprises: from 0.5% to4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 -diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 02% to 4% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0,2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; from 3 to 7% by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0,2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 025% to 08% by weight of lactic acid; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 02% to 4% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.3% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1 % to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 ,1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.2% to 4% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0,2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0,2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1, 1- di
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.2% to 4% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid
- lactic acid from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n
- composition i.e. hydrogen peroxide, organic phophoric acid, lactic acid and solvents
- pH value also applies to the above mentioned composition comprising surfactants.
- the composition of the invention further comprises one or more builders.
- the builder is commonly used for stabilizing the composition.
- the term “builder” encompasses chelating agents (chelators), sequestering agents (sequestrants), detergent builders, water soluble salts thereof and a mixture thereof.
- water soluble builder salts encompasses inorganic alkaline builder salts which may be used alone or in admixture with other builders, but are not limited to, alkali metal or ammonia or substituted ammonium salts of carbonates, silicates, phosphates and polyphosphates, and borates.
- Water soluble organic alkaline builders which are useful in the present invention include alkanolamines and cyclic amines.
- appropriate builders for the present invention include, but without limited to, phosphonic acids and phosphonates, phosphates, amino carboxyl ates and their derivatives including salts of hydroxy ethylenediaminetetraacetic acid (HEDTA), and diethylenetriaminepentaacetic acid, and glutamic acid, N,N-diacetic acid tetrasodium salt (commercially available as Dissolvine GL-47®); pyrophosphates, polyphosphates, ethylenediamine and ethylenediamine derivatives, hydroxy acids, and mono-, di-, and tri-carboxylates and their corresponding acids, aluminosilicates, nitroloacetates and their derivatives, and mixtures thereof.
- organic chelating examples include polyanionic compositions such as poly acrylic acid compounds, N-hydroxyethylenediaminetriacetic acid (HEDTA), ethylenediaminetetraacetic acid (EDTA), nitriiotriaacetic acid (NTA), diethyienetriaminepentaacetic acid (DTPA), ethylenediaminetetraproprionic acid triethylenetetraaminehexaacetic acid (TTHA), and the respective aikaii metal, ammonium and substituted ammonium salts thereof; amino phosphonates including ethylenediaminetetramethylene phosphonates, nitrilotrismethylene phosphonates, and diethylenetriamine-
- Suitable sequestrant agents include water soluble pol carboxylate polymers
- Such homopolymeric and copolymeric chelating agents include polymeric compositions with pendant (— CO2H) carboxylic acid groups and include polyacrylic acid, polymethacrylic acid, polymaleic acid, acrylic acid-methacrylic acid copolymers, acrylic-maleic copolymers, hydrolyzed polyacrylamide, hydrolyzed methacrylamide, hydrolyzed acrylamide-methacrylamide copolymers, hydrolyzed polyacrylonitrile, hydrolyzed polymethacrylonitrile, hydrolyzed acrylonitrile methacrylonitrile copolymers, or mixtures thereof Water soluble salts or partial salts of these polymers or copolymers such as their respective alkali metal (for example, sodium or potassium) or ammonium salts may also be used, Examples of commercially available biodegradable aminocarboxylate or derivative thereof are Dissolvine GL-38®
- the composition further comprises glutamic acid, N,N-diacetic acid tetrasodium salt (commercially available as Dissolvine GL-38®) as builder.
- glutamic acid commercially available as Dissolvine GL-38®
- the amount of builders in the composition of the present invention is from 0.04 to 1% by weight.
- the amount of aminocarboxylate builders, particularly N,N-diacetic acid tetrasodium salt (commercially available as Dissolvine GL-38®) is from 0.04 to 0.1 % by weight.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 025% to 08% by weight of lactic acid; from 004 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid
- lactic acid from 004 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- amphoteric surfactants as defined above
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 0,5% to 4% by weight of hydrogen peroxide; from 0.1% to 0,5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid
- lactic acid from 0.2% to 4% by weigt of non-ionic surfactants as defined above
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; from 3% to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.04 to 1 % by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid
- lactic acid from 0.1% to 6.5% by weigt of surfact
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0,2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; from 3% to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diace
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 3% to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1 - diphosphonic acid
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid
- lactic acid from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic
- the composition of the invention comprises: from 1 % to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; from 0.04 to 1 % by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1 % to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1, 1- diphospho
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 03% to 075% by weight of lactic acid; from 02% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; from 004 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid
- non-ionic surfactants as defined above
- non-ionic surfactants as defined above
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 6.5% by weigt of surfactants; from 3% to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.04 to 1 % by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid
- from 0.3% to 0.75% by weight of lactic acid from 0.1% to 6.5% by
- the composition of the invention comprises: from 1 % to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 0.2% to 4% by weigt of non-ionic surfactants as defined above; particularly C8/C10 wheat bran glycoside, capryloyl/capryl methyl glucamide or a mixture thereof; from 3% to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid, particularly
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 3% to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 004 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1, 1- diphosphonic acid
- the composition of the invention comprises: from 1% to 3% by weight of hydrogen peroxide; from 0.2% to 0.35% by weight of an organic phosphonic acid, particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid; from 0.3% to 0.75% by weight of lactic acid; from 0.1% to 2.5% by weigt of amphoteric surfactants as defined above; particularly decyldimethyl-aminoxide; from 3 to 7 % by weight of one or more solvents, particularly ethanol, di (propylene glycol) n-butyl ether and di(propylene)glycol and mixture thereof; from 0.04 to 1% by weight of one or more builders, particularly aminocarboxylate builder such as glutamic acid, N,N-diacetic acid tetrasodium salt; and having a pH from 2 to 3.6; particularly from 2.4 to 3.2.
- an organic phosphonic acid particularly 1 -hydroxyethylidene-1 , 1- diphosphonic acid
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of an organic phosphonic acid; from 0.25% to 0.8% by weight of lactic acid; from 0.1 to 6.5% by weight of surfactats; from 3 to 7% by weight of solvents; and from 0 to 1% by weight of builders; being the sum of all the components up to 100% by weight; and having a pH from 2 to 3.6.
- the composition of the invention comprises: from 0.5% to 4% by weight of hydrogen peroxide; from 0.1% to 0.5% by weight of 1-hydroxyethylidene-1 , 1-diphosphonic acid (HEDP); from 0.25% to 0.8% by weight of lactic acid; from 0.1 to 2.5 % by weight of decyldimethyl-aminoxide; from 0.2 to 4 % by weight of C8/C10 wheat bran glycoside; from 0 to 4 % by weight of capryloyl/capryl methyl glucamide; from 3 to 7 % by weight of ethanol from 0 to 1% by weight of glutamic acid, N,N-diacetic acid tetrasodium salt; sufficient amount up to 100% by weight of water; being the sum of all the components up to 100% by weight; and having a pH from 2 to 3.6. All the embodiment disclosed in the present invention for the components of the composition (i.e. hydrogen peroxide, organic phophoric acid, lactic acid, solvents, surfact
- composition of the present invention can also include other conventional additives, provided each ingredient is compatible with the other ingredients of the composition and the presence of the ingredient does not adversely affect the stability and the properties of the composition.
- Each additional ingredient may be used to modify the composition of the present invention in a conventional way and may be present in an effective amount, that is, in the amount required to achieve the desired disinfecatnt and cleaning effect without adversely affecting its stability, toxicity and material compatibility.
- Examples of conventional additives are selected from the group consisting of thickening/viscosity modifying agent, perfumes or fragrances, preservatives; dyes and other colorants; UV absorbents or antioxidizing agents, fabric softening compositions; static control agents; optical opacifiers, such as polystyrene particles; and suds regulants, such as dimethylpolysiloxane.
- the appropriate additional conventional additives as defined above and their amounts, can readily be determined by those skilled in the art according to the type of formulation being prepared.
- the composition of the present invention has a pH from 2 to 3.6.
- the composition has a pH from 2 to 3.5.
- the composition has a pH from 2.4 to 3.5.
- the composition has a pH from 2.4 to 3.2.
- the composition has a pH from 2.8 to 3.2.
- the pH is measured using the methods known in the state of the art. In the present invention, the pH is measured according to the CIPAC guideline MT75.3. This pH is the appropriate for having a stable, non-toxic and an efficient disinfectant and cleaning properties.
- the composition further comprises one or more pH adjusting agents.
- pH adjusting or “pH regulator” agent have the same meaning and are used interchangeable. They refer to acids or bases that can be used to adjust the pH of the finished composition to the desired level, without affecting the stability of the composition and its disinfectant and cleaning properties.
- the acid(s) and/or base(s) may be added to the composition in any suitable form, such as anhydrous, hydrated, aqueous or salt.
- the pH adjusting agent is a base.
- appropriate bases include alkali metal and alkaline earth metal hydroxides, ammonium hydroxide, substituted ammonium hydroxides (such as primary, secondary, tertiary, or quaternary ammonium hydroxides), and mixtures thereof.
- the pH adjusting agent is an acid.
- appropriate acids include sulfur-containing acid, such as a sulfonic acid, sulfuric acid, an alkali metal bisulfate, phosphoric acid and nitric acid. If present, the amount of the pH adjusting agent in the composition of the present invention is such for having the appropriate pH value of the compositions of the present invention.
- the composition further comprises one or more pH buffering agents.
- pH buffering agent is an acid in a sufficient amonut that control the pH into the desired acidic pH range of the composition as defined above.
- the presence of one or more pH buffering agent allows minimizing the pH changes, particularly after dilution.
- appropriate pH buffering agent include weak inorganic acids of phosphoric acid, strong organic acids of sulfonic acids, weak organic acids of phosphoric acid, phosphonic acid, boronic acid and mono- or multi-carboxylic acid (such as acetic acid, citric acid). If present, the amount of the pH buffering agent in the composition of the present invention is from 0.25 to 0.50 % by weight.
- the composition of the first aspect of the invention may be packaged and used to treat a given surface in any suitable format known to one of ordinary skill in the art, such as liquid compositions, foam composition, gel composition or impregnated on solid surfaces (such as wipes).
- the composition of the invention is in liquid format.
- the liquid format is a water-based solution composition which can be in form of spray, aerosol, bottle, doypack and sachet.
- the liquid compositions of the present invention may be packaged in manually operated dispensing containers (such as a trigger or a pump dispenser). In such a dispenser, the liquid composition may be divided in fine liquid droplets resulting in a spray/aerosol that is directed onto the surface to be treated.
- the composition of the invention is in gel format.
- the composition when the composition is a gel, the composition further comprises one or more jellifying agents.
- jellifying agents and their amounts, can readily be determined by those skilled in the art according to the type of formulation being prepared. Examples of appropriate jellifying agents include, acrylates/palmeth- 25 acrylate copolymer (POLYGEL W301), 2-propenoic acid, homopolymer (POLYGEL CA) and a mixture thereof.
- POLYGEL W301 acrylates/palmeth- 25 acrylate copolymer
- POLYGEL CA 2-propenoic acid
- POLYGEL CA homopolymer
- the gel compositions of the present invention may be packaged in manually operated dispensing containers, bottle, doypack and sachet.
- the composition of the invention is in foam format.
- the composition further comprises one or more foaming agents.
- foaming agents and their amounts can readily be determined by those skilled in the art according to the type of formulation being prepared.
- appropriate foaming agents include any of the surfactants as defined above in the present invention.
- the foam compositions of the present invention may be packaged in manually operated dispensing containers.
- the composition of the invention is in wipes format such as disposable towels incorporated/impregnated/wetted with the composition of the first aspect of the invention.
- the second aspect of the invention relates to a process for the preparation of the composition of the first aspect of the invention.
- compositions of the present invention can be prepared according to methods well known in the state of the art according to the type of formulation being prepared.
- the process for the preparation of the composition of the first aspect of the invention comprises:
- Step b) adding the hydrogen peroxide and the lactic acid simutaneously or sequentially to the resulting aqueous mixture obtained in step a) until having a composition having a pH from 2 to 3.6; and optionally step c) adjusting the volume of the mixture obtained in step b) by adding the appropriate amount of water.
- the process for the preparation of the composition of the first aspect of the invention comprises:
- fragrance such as surfactants, solvents and builders
- Step a' adding the fragrance to the resulting mixture of step a);
- Step b) adding the hydrogen peroxide and the lactic acid simutaneously or sequentially to the resulting aqueous mixture obtained in step a) until having a composition having a pH from 2 to 3.6.
- steps a), a'), b) and c) are performed under continuously stirring. In an embodiment, steps a), a') and b) are performed at room temperature.
- room temperature refers to a temperature of the environment, without heating or cooling, and it is generally from 20°C to 25°C.
- step a) is performed by simultaneoulsy addition of the organic phosphonic acid and the additives (if present).
- step b) comprises: firstly, adding the organic phosphonic acid; and secondly the simultaneulsly or sequentcially addition of the additives (if present). The addition of the additives can be performed in any order.
- step b) is performed by simultaneoulsy addition of the hydrogen peroxide and the lactic acid.
- step b) comprises: firstly, the addition of the hydrogen peroxide followed by the addition of the lactic acid.
- step a) comprises mixing from 80% to 100% of the total amount of water for providing the aqueous mixture containing the organic phosphonic acid of step a).
- composition of the first aspect of the invention comprises: c) providing an aqueous mixture of the organic phosphonic acid, the lactic acid and, if present, the additives (such as surfactants, solvents and builders); and d) adding separately the hydrogen peroxide and water to the resulting mixture of step c), wherein the addition is performed simutaneously or sequentially until obtaning a composition having a pH from 2 to 3.6.
- the additives such as surfactants, solvents and builders
- This process is advantegeous because can be perfomed in batches or in a continuous form.
- steps c) and d) are performed under continuously stirring. In an embodiment, steps c) and d) are performed at room temperature.
- step c) is performed by simultaneoulsy addition of the organic phosphonic acid and the additives (if present).
- the addition of the additives can be performed in any order.
- the third aspect of the invention relates to the use of the composition of the first aspect of the invention as disinfectant and cleaner.
- the terms "disinfectant” and “disinfecting” have the same meaning and are used interchangeable. They refer to its ability of destroying, detering, rendering harmless and/or exerting a controlling effect on any harmful organism (including bacteria, fungi, spores, viruses, moulds and yeast), which exist on a non-living surface.
- a composition is considered effective as a disinfectant having bactericidal and fungicidal activity wherein the composition complies with the bactericide and fungicide activity of the UNE- EN13697:2015 regulation on surfaces, which includes between others, Pseudomona aeroginosa and
- composition of the present invention reduces at least in a number of 4 logaritmic units against Pseudomona aeroginosa and at least in a number of 3 logaritmic units against Aspergillus brasiliensis as it is shown in the experimental section.
- a composition is considered effective as a disinfectant having viricidal activity wherein the composition reduces at least in a number of 4 logaritmic units against rellevant virus such as Vacciniavirus and Coronavirus 229E as it is shown in the experimental section.
- composition of the invention includes the effective amount of each ingredient for performing its disinfecting action.
- composition of the present invention is also appropriate for being used as cleaner agent.
- cleaning agent or “cleaning composition” refers to a composition that when applied to non-living surfaces, effectively removes foreign matter located on the surface.
- cleaning encompasses composition capable of removing lime, soap (foam, scum and stains) and grease from non- living surfaces.
- a composition is considered effective as cleaning agent wherein the laboratory results according to the IKW method (available in the website https://www.ikw.org/fileadmin/ikw/downloads/Flaushaltswit/FIP__EQ__AZR__2017__E.pdf on May 5th, 2020) show a low amount of traces (equal to or lower than 2.5) and a cleaning between 6-10 out of 10; and the removal of lime and soap residues is over 70% as it is shown in the experimental section. It is also part of the invention a method for disinfecting and cleaning a non-living surface comprising contacting the non-living surface with the composition of the first aspect of the present invention.
- non-living surfaces encompasses hard-surfaces such as those typically found in hospital environments (e.g., operating theatres, surgical areas, recovery areas, moveable equipment such as gurneys, beds, and the like), medical laboratories, medical treatment environments, food services, food processing, and those found in residential and commercial spaces like kitchens, bathrooms, such as tiles, walls, floors, chrome, glass, smooth vinyl, any plastic, plasticized wood, table top, sinks, cooker tops, dishes, sanitary fittings such as sinks, showers, shower curtains, wash basins and toilets.
- non-living surfaces also include objects such as medical tools and food services equipment such as utensils.
- the method for disinfecting and cleaning of the present invention comprises contacting the surface with the composition for an exposure time from 1 min to 15 min, depending on the activity to reach,
- the compositions of the present invention are non-toxic non irritant and allows having an efficient disinfectant activity and achieving a very thorough and at the same time broad cleaning effect with a short exposure time and without causing damage to the surface to be treated.
- compositions of the invention are 1.1. Compositions of the invention
- Tables 1 and 2 show the composition of the invention which have cleaning effect and effective disinfectant activity.
- the comparative compositions 1, 4, 5, 7 and 9 comprise an amount of lactic acid outside the claimed ranges (the amount of lactic acid in the Comp. Ex. 1 and 4 is higher than the claimed range, and in the Comp. Ex. 5, 7 and 9 is lower than the claimed range). Further, comparative compositions 1 and 4 do not comprise an organic phosphonic acid; and the comparative composition 5 also has a pH value higher than the claimed range. Besides, comparative compositions Examples 6 and 8 do not contain lactic acid. And, the comparative compositions 2 and 3 contain formic acid instead of lactic acid.
- compositions of the invention and the comparative composition as defined above were prepared following the general process as defined below using the ingredients and the amounts specified in Tables 1, 2 and 3 respectively.
- Step a) In a recipient with the 90% of the amount of the total water specified in the corresponding table; the organic phosphonic acid, and, if present, the additives (such as surfactants, solvents, builders and fragrances) were sequentially added under stirring until a transparent solution is obtained;
- the additives such as surfactants, solvents, builders and fragrances
- Step b) The hydrogen peroxide was added to the resulting mixture obtained in step b) under stirring, followed by the addition of the acid until adjusting the pH of the solution to that specified in the corresponding table; and Step c) the 20% of the amount of water was added to the solution obtained in step c) to obtain the final composition.
- the resultant compositions can be conditioned in small recipients of 100ml or in big reactors of 30 Tn.
- the fragrances can be added separately to the rest of additives (which are added in step a), Partiuclarly, the fragrances can be added to the resulting mixture obtained in step a) maintaining the stirring until an homogeneous solution was obtained (step a').
- the tested compositions were stored at 54°C ⁇ 2°C during 2 weeks period in its commercial packaging material (PE bottle). Only Example 5 was stored at 40°C during 12 weeks, which is an equivalent condition of stability.
- the determination of the hydrogen peroxide content from the tested compostions was performed according to CIPAC MT46.3 protocol. The % of degradation is calculated using the following equation:
- compositions of the present invention comprising the hydrogen peroxide, the organic phosphonic acid and the lactic acid in the claimed amounts meets the specifications stablish by the FAO/WHO to guarantee a toxicological safety and ensuring an appropriate disinfectant and cleaning effectivenes.
- the aim of the below-disclosed tests is the evaluation of the biocide activity of the compositions of the present invention in comparison with the comparative compositions falling outside the scope of the present invention.
- the bactericidal, fungicidal and/or viricidal activity were measured for the tested compositions (Examples 1, 2, 4, 5 and 7; and Comp. Ex. 6, 7 and 8).
- the procedure of the disinfectant test is based on the European Norms (Guidance on the Biocidal Product Regulation):
- Phase II - step I UNE-EN1276:2010 (5 min), UNE-EN1650:2008+A1 :2013 (15 min);
- Phase II - step II Phase II - step II: UNE-EN13697:2015 (5 min bacteria and 15 min fungi);
- Phase II - step I UNE-EN14476:2014 (vaccinia) (5 min); based on EN14476:2013 (HiNi virus and herpes virus) (5 min); based on NF-EN14476:2013+A2:2019 (Pluman coronavirus 229 E) (5 min);
- the tested microorganisms, fungui and virus of study were: Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus hirae (EH), Escherichia coli, Candida albicans, Aspergillus brasiliensis (AB), H1N1 Virus, Human Coronavirus 229E and Vaccinia Virus.
- compositions of the present invention are biocide.
- the compositions of the invention show a triple bactericidal, fungicidal and viricidal activity even of comprising a low amount of hydrogen peroxide from 0.5 and 2% by weight (Ex. 1, 2, 4 and 5).
- the comparative compositions which does not contain lactic acid (Comp. Ex. 6 and 8) or contain it in a very low amount falling outside of the claimed range (Comp. Ex. 7 having a 0.09%) do not have an efficient disinfectant effect.
- the inefficient disinfectant effect is not enhanced even of increasing the amount of hydrogen peroxide until 2.5% by weight (Comp. Ex. 9).
- the aim of the below-disclosed tests is the qualitatively evaluation of the cleaning capacity of the compositions of the present invention in comparison with the comparative compositions falling outside of the scope of the present invention.
- the anti-lime and soap removal capability, the traces evaluation test and the degreasing effect are measured.
- the lime and soap removal effect of the compositions of the present invention was performed.
- the aim of this test is the qualitative and quantitative evaluation of the cleaning capacity of the above-mentioned tested compositions regarding the removal of lime and soap from surfaces.
- the procedure is based in the contact for 5 min of the tested compositions with a surface impregnated with a mixture of lime and soap.
- the hard surface can be a metal or ceramic tile as these are the most representative surfaces in the domestic area. After 5 min of exposition, the surface must be treated with distilled water and the efficacy is evaluated.
- the capacity of removing the lime from the surface shows the efficacy of the composition on the surface using a visually scale rate.
- the scale rate was determined by the evaluation of the circle of the tile
- the results are expressed as follows: The degree of lime and soap removal is expressed in percentage in relation to the initial amount. The higher the percentage, the better the lime scale and soap removal effect.
- the amount of traces on the surface are scored from 0 to 10, being 0 the no presence of traces (total elimination of visual residues) and 10 the nule elimination of visual residues.
- the score number the better the traces removal.
- the degreasing Evaluation Test of the compositions of the present invention (Ex. 2 and 4) was performed.
- the aim of this test is the quantitative evaluation of the amount of grease and particulate dirt that remains on the treated surface after the application of the tested compositions.
- the method used is the HP_EQ_AZR_2017_E protocol (IKW Recommendation for the Quality Assessment of the Product Performance of All-Purpose Cleaners 2014).
- the amount of grease on the surface are scored from 0 to 10, being 0 the nule elimination of grease and 10 the no presence of grease (total elimination of grease). Thus, the higher the score number, the better the grease removal.
- compositions of the present invention are capable of being used as cleaning compositions.
- they have a high efficiency for as anti-lime agent and also useful for the removal of soap removal in the commonly used surfaces at both homeplace and workplace, including delicate surfaces such as metal surfaces and organic based surfaces.
- the composition of the present invention are also effective as degreasing agent giving at the same time a brightness to the treated surface without damaging it.
- the aim of this test is the quantitatively evaluation of aggression of on a marble plate caused by the above- mentioned tested compositions.
- the procedure is based in the contact of marble block specimens with the tested composition for 5 min and after that time, the evaluation of the weight's loss of the CaCOe because of the effect of the composition was determinted.
- compositions of the present invention have not a high impact in the deposits of CaCOe even though with high concentrations of lactic acid. Furthermore, these results also show that the change of the lactic acid for another acid such as formic acid in the same amount (Comp. Ex. 2 and 3) do neither result in an enhancement of the aggression to the marble plates.
- compositions of the present invention (Ex. 2 and 5) were submitted to the material compatibility test based on the UNE-EN 13442 (Wood floors and interior and exterior wood wall coverings. Determination of resistance to chemical agents) changing the paper surface by a calcareum or metallic surface
- the aim of this test is the qualitatively evaluation of the damage caused by the application of the above- mentioned tested compositions over the above-mentioned hard surfaces.
- the objective is the determination of the resistance of the carcareoum or metallic element to a predetermined ratio of chemical agents to which it could be exposed during its service life.
- UNE-EN 13442 Method A paper impregnated with one of the above-mentioned tested composition was placed on the test surface and covered with a Petri dish to prevent evaporation.
- the paper is removed, the test surface is washed and dried, and visible changes are analyzed. These changes are evaluated against a numerical classification code.
- the duration established for each of the tested surfaces is 24h (+/- 1). After that time, the Petri dish and filter paper are removed with the clamp. Paper fibers adhering to the test surface are not removed (if any). Excess tested composition is absorbed with the absorbent paper or cloth without rubbing and the surface is left to stand for 24 hours without covering. - After 24 hours of rest, the test surface is cleaned by lightly rubbing it with the absorbent paper or cloth soaked in the cleaning solution and then with another soaked in distilled water. Finally, the surface is carefully cleaned with a dry cloth.
- the reference area of the test surface that has not been exposed to the tested composition is cleaned and dried in the same way. - The tested surface is left uncovered (30 ⁇ 1) min uncovered.
- results the damage caused by the tested compositions was evaluated by visual examination. A numerical value is associated to the tested area in comparison to the reference area, which has not been exposed to the tested compositions according to the following classification code:
- composition of the present invention (Ex. 5) was submitted to the in-use test under dermatological control by the assestment of the cutaneous acceptability of the tested composition, applied under the normal conditions of use for 3 weeks.
- the aim of this test is the determination of the attack of the integrity of the skin by lesions in the epidermis and the appearance of an inflammatory reaction in the dermis, resulting in macroscopically visible phenomena, which manifests from a redness (erythema) to edema.
- the use test is performed under Dermatological control allowing the verification of the absence of discomfort reactions or cumulative irritation associated to the application of the tested composition for 3-4 weeks in normal conditions of use, under subjects who met specific inclusion criteria.
- Application conditions by the subjects themselves, at home (starting on D1 and ending on D21) under the normal conditions of use.
- UNE-EN 13442 Wood floors and interior and exterior wood wall coverings. Determination of resistance to chemical agents
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20382501.3A EP3922706A1 (en) | 2020-06-10 | 2020-06-10 | A disinfectant and cleaning composition |
PCT/EP2021/065377 WO2021250049A1 (en) | 2020-06-10 | 2021-06-09 | A disinfectant and cleaning composition |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4165158A1 true EP4165158A1 (en) | 2023-04-19 |
EP4165158B1 EP4165158B1 (en) | 2023-11-15 |
Family
ID=71130912
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20382501.3A Withdrawn EP3922706A1 (en) | 2020-06-10 | 2020-06-10 | A disinfectant and cleaning composition |
EP21730617.4A Active EP4165158B1 (en) | 2020-06-10 | 2021-06-09 | A disinfectant and cleaning composition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20382501.3A Withdrawn EP3922706A1 (en) | 2020-06-10 | 2020-06-10 | A disinfectant and cleaning composition |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP3922706A1 (en) |
ES (1) | ES2969795T3 (en) |
WO (1) | WO2021250049A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9604413D0 (en) * | 1996-11-29 | 1996-11-29 | Eka Chemicals Ab | Chemical composition |
US7256167B2 (en) * | 2001-08-31 | 2007-08-14 | Reckitt Benckiser Inc. | Hard surface cleaner comprising suspended particles and oxidizing agent |
US20080305182A1 (en) * | 2002-11-15 | 2008-12-11 | Ramirez Jose A | Hydrogen peroxide disinfectant containing a cyclic carboxylic acid and/or aromatic alcohol |
US20090324508A1 (en) * | 2006-07-06 | 2009-12-31 | Centennial Ventures B.V. | Broad Spectrum and Skin Friendly Disinfecting Composition |
JP7149072B6 (en) * | 2014-09-09 | 2024-02-02 | アークサーダ・リミテッド・ライアビリティ・カンパニー | Disinfecting composition containing a quaternary ammonium compound |
-
2020
- 2020-06-10 EP EP20382501.3A patent/EP3922706A1/en not_active Withdrawn
-
2021
- 2021-06-09 EP EP21730617.4A patent/EP4165158B1/en active Active
- 2021-06-09 ES ES21730617T patent/ES2969795T3/en active Active
- 2021-06-09 WO PCT/EP2021/065377 patent/WO2021250049A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3922706A1 (en) | 2021-12-15 |
EP4165158B1 (en) | 2023-11-15 |
WO2021250049A1 (en) | 2021-12-16 |
ES2969795T3 (en) | 2024-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7149072B2 (en) | Disinfectant composition containing quaternary ammonium compound | |
US6106774A (en) | Ready to use aqueous hard surface cleaning and disinfecting compositions containing hydrogen peroxide | |
JP5932802B2 (en) | Antibacterial composition containing a cationic active ingredient and a surfactant derived from a quaternary sugar | |
EP2236594B1 (en) | Method for removing biofilms | |
WO2012080918A2 (en) | Wear resistant antimicrobial compositions and methods of use | |
JP6991959B2 (en) | Antibacterial cleaner composition | |
AU2020272127B2 (en) | Antimicrobial multi-purpose cleaner and methods of making and using the same | |
WO2015078496A1 (en) | Disinfectant cleaner composition having tuberculocidal efficacy and efficacy against specific viruses | |
JP5248326B2 (en) | Enhanced activity biocidal hydrogen peroxide composition | |
EP1876225A1 (en) | Broad spectrum and skin friendly disinfecting composition | |
AU741177B2 (en) | Method of disinfecting and inhibiting mold and mildew growth on non-porous hard surfaces | |
JP5466904B2 (en) | Cleaning method for medical equipment | |
JP2009149858A (en) | Cleaning agent composition for hard surface | |
EP4165158B1 (en) | A disinfectant and cleaning composition | |
US12043820B2 (en) | Hard surface cleaning composition | |
WO2024083715A1 (en) | Cleaning composition | |
CA3077837A1 (en) | Hard surface cleaner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230110 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20230613 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602021006886 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240216 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1631808 Country of ref document: AT Kind code of ref document: T Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240315 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240216 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240215 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240315 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2969795 Country of ref document: ES Kind code of ref document: T3 Effective date: 20240522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240215 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240625 Year of fee payment: 4 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602021006886 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240701 Year of fee payment: 4 |
|
26N | No opposition filed |
Effective date: 20240819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231115 |